資源描述:
《常規(guī)超聲與超聲造影及增強CT對彌漫性肝癌的診斷價值比較.pdf》由會員上傳分享,免費在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、西部醫(yī)學(xué)2017年4月第29卷第4期MedJWestChina,April2017,Vol.29,No.4·519··論著·常規(guī)超聲與超聲造影及增強CT對彌漫性肝癌的診斷價值比較*覃夏川11112劉學(xué)彬馬果豐楊姣蔣國霞(1.川北醫(yī)學(xué)院第二臨床醫(yī)學(xué)院·南充市中心醫(yī)院超聲科,四川南充637000;2.越西縣人民醫(yī)院超聲科,四川越西616650)【摘要】目的比較常規(guī)超聲、超聲造影及增強CT對彌漫性肝癌的診斷價值。方法回顧性分析42例彌漫性肝癌患者的常規(guī)超聲、超聲造影和增強CT表現(xiàn),并對三種檢查診斷結(jié)果進(jìn)行對比。結(jié)果常規(guī)超聲對彌漫性肝癌的診斷準(zhǔn)確率為38.1
2、%(16/42),超聲造影對彌漫性肝癌的診斷準(zhǔn)確率為81.0%(34/42),增強CT對彌漫性肝癌的診斷準(zhǔn)確率為83.3%(35/42)。超聲造影與增強CT對彌漫性肝癌的診斷準(zhǔn)確率明顯高于常規(guī)超聲(P<0.05);超聲造影和增強CT診斷的準(zhǔn)確率比較,差異沒有統(tǒng)計學(xué)意義(P>0.05)。結(jié)論與常規(guī)超聲檢查結(jié)果相比,超聲造影提高了彌漫性肝癌的診斷準(zhǔn)確率,且與增強CT診斷準(zhǔn)確率相近?!娟P(guān)鍵詞】超聲造影;增強CT;彌漫性肝癌;門靜脈癌栓【中圖分類號】R445.1【文獻(xiàn)標(biāo)志碼】Adoi:10.3969/j.issn.1672-3511.2017.04.016T
3、heroleofcontrast-enhancedultrasoundinthediagnosisofdiffusehepatocellularcarcinoma1,LIUXuebin1,MAGuofeng1,YANGJiao1,JIANGGuoxia2QINXiachuan(1.DepartmentofUltrasonograhy,NanchongCentralHospital,Nanchong637000,Sichuan,China;2.DepontmentofUltrasonogrophy,YuexiDeopleHospital,yuexi61
4、6650,Sichuan,China)【Abstract】ObjectiveTocomparethediagnosticvalueofconventionalultrasonography,contrast-enhancedultrasonogra-phy(CEUS)andcontrast-enhancedCTindiffuse-typehepatocellularcarcinoma(D-HCC).Methods42D-HCCpatientsweretreatedwithconventionalultrasound,ultrasonicimaging
5、andenhancedCTperformance.ResultsTheaccuracyidentifyD-HCCofconventionalultrasonography,CEUSandcontrast-enhancedCTwerewas38%(16/42),81%(34/42)and83%(35/42).TheaccuratediagnosisratesintheCEUSandcontrast-enhanceCTweresignificantlyhigherthanthatintheconventionalultrasonog-raphy(P<0.
6、05).TherewasnodifferencebetweenCEUSandcontrast-enhanceCT.ConclusionsComparedwithconventionalultrasonography,CEUScanincreasethediagnosticaccuracyintheD-HCC.Thatissimilartocontrast-enhanceCT.【Keywords】Contrast-enhancedultrasound;Contrast-enhancedCT;Diffuse-typehepatocellularcarci
7、noma;Portalvenoustumorthrombosis原發(fā)性肝細(xì)胞癌(Hepatocellularcarcinoma,融入肝硬化背景中,在影像上缺乏腫瘤破壞的邊界影HCC)是全球癌癥死亡的第三大惡性腫瘤,HCC根據(jù)像。目前,常規(guī)超聲由于其方便及價錢便宜,作為肝病理特征可以分成三型:結(jié)節(jié)型,團塊性,彌漫型[1]。[4-7]硬化患者最重要的隨訪工具被廣泛用于臨床,但彌漫型肝癌(diffuse-typehepatocellularcarcinoma,D-新近研究認(rèn)為,其對肝癌的檢出效能并不高[8]。隨著HCC)表現(xiàn)為肝內(nèi)彌漫性均勻分布大小不等的腫
8、瘤結(jié)第二代超聲造影劑和實時對比成像技術(shù)的發(fā)展,超聲[2][3]節(jié),彌漫型肝癌占整個HCC的比例約為13%。造